About John
Mr. Erwin focuses his practice on mergers and acquisitions, biotechnology and health care. Mr. Erwin's clients include both foreign and domestic businesses in the industrial and service sectors, as well as technology companies and health care providers. He regularly serves as counsel and legal advisor to corporations, other businesses and health care providers on a variety of issues, including: Stock and asset purchases and sales, mergers, acquisitions and similar transactions, Strategic joint ventures and other complex commercial transactions, Transactions involving biotechnology,Technology transfer and licensing agreements, Health care compliance, Managed care and other agreements for health care providers, and International transactions.
Mr. Erwin focuses his practice on mergers and acquisitions, biotechnology and health care. Mr. Erwin's clients include both foreign and domestic businesses in the industrial and service sectors, as well as technology companies and health care providers. He regularly serves as counsel and legal advisor to corporations, other businesses and health care providers on a variety of issues, including: Stock and asset purchases and sales, mergers, acquisitions and similar transactions, Strategic joint ventures and other complex commercial transactions, Transactions involving biotechnology,Technology transfer and licensing agreements, Health care compliance, Managed care and other agreements for health care providers, and International transactions.
Mr. Erwin focuses his practice on mergers and acquisitions, biotechnology and health care. Mr. Erwin's clients include both foreign and domestic businesses in the industrial and service sectors, as well as technology companies and health care providers. He regularly serves as counsel and legal advisor to corporations, other businesses and health care providers on a variety of issues, including: Stock and asset purchases and sales, mergers, acquisitions and similar transactions, Strategic joint ventures and other complex commercial transactions, Transactions involving biotechnology,Technology transfer and licensing agreements, Health care compliance, Managed care and other agreements for health care providers, and International transactions.
